Posts written by zimmers


MIMG’s Magnificent 7 – Yanan “Jackie” Zhu, Ph.D.

October 3, 2023

No project information available at the time of publication.




MIMG’s Magnificent 7 – Wei-Bei Wang, Ph.D.

October 3, 2023

No project information available at the time of publication.




MIMG’s Magnificent 7 – Carlo Vanz, Ph.D.

October 3, 2023

Application of obesity mouse model to begin exploring why obesity causes a decrease in vaccine efficacy.




MIMG’s Magnificent 7 – Cheshta Sharma, Ph.D.

October 3, 2023

Working on the elucidation of novel molecular mechanisms of antifungal resistance and virulence in a multidrug resistant human fungal pathogen, Candida auris.




MIMG’s Magnificent 7 – Carlos Rivera, Ph.D.

October 3, 2023

We generated a new and advanced humanized mouse model, THX mice, which mount mature T-dependent and T-independent antibody responses to conjugated haptens and microbial components, and are also amenable to develop full-blown lupus-like autoimmune disease.  Such advancements allow for the study of human antibody and autoantibody responses, along with the mechanisms underpinning the maturation of […]




MIMG’s Magnificent 7 – Longhuan “Harry” Ma, Ph.D.

October 3, 2023

We are investigating the role of gut microbiome changes on the initiation and progression of systemic lupus erythematosus (SLE). We identified an anaerobic, gram-positive bacterium, Ruminococcus gnavus (Rg),  which expands in the gut microbiome of lupus-prone mice and its blooms showed positive correlation with lupus diseases activities.   Rg depletion with antibiotics ameliorated lupus autoimmunity with increased […]




MIMG’s Magnificent 7 – Li He, Ph.D.

October 3, 2023

Determining the efficacy of the polymerase and exoribonuclease inhibitors against SARS-CoV-2. We use the recombinant SARS-CoV-2 virus that expresses mCherry or luciferase to quantify the antiviral activity of the inhibitors.




See a PostDoc…Thank a PostDoc

October 3, 2023

UT Health San Antonio has over 160 postdoctoral research fellows from 29 countries.  MIMG is extremely proud of the “MIMG Magnificent 7” who are exceptional early-career scientists working on the “incredible, innovative and ground-breaking biomedical research and discovery that our institution is known for.”    



David Kadosh, Ph.D. receives R56 Award

October 3, 2023

Dr. David Kadosh was awarded an R56 from NIH recently “Regulation of Candida albicans gene expression in response to host environmental stresses.” Project period is 8/1/23-7/31/24.  Congratulations.



Lab Pumpkin Decorating Contest

October 3, 2023

MIMG will purchase one pumpkin for each lab who chooses to participate and decorate for the Halloween season. Watch your email for more info. Time to start planning your theme.  The MIMG pumpkin patch (AKA the Admin Suite) will open on Friday, Oct 6th @ 10:00 am.